Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis

A Nishiyama, XH Lin and WB Stallcup

La Jolla Cancer Research Foundation, CA 92037, USA.

NG2 is a chondroitin sulfate proteoglycan that is expressed on dividing progenitor cells of several lineages including glia, muscle, and cartilage. It is an integral membrane proteoglycan with a core glycoprotein of 300 kDa. In the present study we have characterized three molecular forms of the NG2 core protein expressed by different cell lines. Many cell lines that express the full length 300-kDa NG2 core protein also release a 290-kDa form into the medium. This species lacks the cytoplasmic domain but contains almost the entire ectodomain. Two core protein species, the intact 300-kDa form and a truncated 275- kDa form, are expressed at the surface of an NG2-transfected cell line U251NG52. The 275-kDa species lacks the cytoplasmic domain and at least 64 amino acids of the ectodomain. Mild trypsinization of B49 cells also generates the 275-kDa species, suggesting that this component is produced by proteolysis of the 300-kDa form. Conversion of the 300-kDa species to the 275-kDa form in U251NG52 cells is stimulated by reagents such as phorbol esters, which activate protein kinase C. Phorbol esters are also known to induce expression of metalloproteinases such as collagenase and stromelysin, which could be responsible for cleavage of the 300-kDa core protein. Although B49 cells do not spontaneously produce the truncated 275-kDa species, use of monoclonal antibodies against NG2 to block the interaction between NG2 and type VI collagen results in the appearance of the 275-kDa component in these cells. Thus the interaction between NG2 and type VI collagen, which contains a Kunitz-type proteinase inhibitor sequence in the alpha 3 chain, may protect the proteoglycan against proteolysis. This is consistent with the observed deficiency of U251NG52 cells in anchoring type VI collagen at the surface.

Volume 6, Issue 12, pp. 1819-1832, 12/01/1995
Copyright © 1995 by The American Society for Cell Biology

This article has been cited by other articles:

				I. T. Makagiansar, S. Williams, K. Dahlin-Huppe, J.-i. Fukushi, T. Mustelin, and W. B. Stallcup Phosphorylation of NG2 Proteoglycan by Protein Kinase C-{alpha} Regulates Polarized Membrane Distribution and Cell Motility J. Biol. Chem., December 31, 2004; 279(53): 55262 - 55270. [Abstract] [Full Text] [PDF]

				J.-i. Fukushi, I. T. Makagiansar, and W. B. Stallcup NG2 Proteoglycan Promotes Endothelial Cell Motility and Angiogenesis via Engagement of Galectin-3 and {alpha}3{beta}1 Integrin Mol. Biol. Cell, August 1, 2004; 15(8): 3580 - 3590. [Abstract] [Full Text] [PDF]

				J. Legg, U. B. Jensen, S. Broad, I. Leigh, and F. M. Watt Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis Development, December 15, 2003; 130(24): 6049 - 6063. [Abstract] [Full Text] [PDF]

				P. H. Larsen, J. E. Wells, W. B. Stallcup, G. Opdenakker, and V. W. Yong Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan J. Neurosci., December 3, 2003; 23(35): 11127 - 11135. [Abstract] [Full Text] [PDF]

				Y. M. Ughrin, Z. J. Chen, and J. M. Levine Multiple Regions of the NG2 Proteoglycan Inhibit Neurite Growth and Induce Growth Cone Collapse J. Neurosci., January 1, 2003; 23(1): 175 - 186. [Abstract] [Full Text] [PDF]

				L. L. Jones, Y. Yamaguchi, W. B. Stallcup, and M. H. Tuszynski NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors J. Neurosci., April 1, 2002; 22(7): 2792 - 2803. [Abstract] [Full Text] [PDF]

				W. B. Stallcup and K. Dahlin-Huppe Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization J. Cell Sci., March 8, 2002; 114(12): 2315 - 2325. [Abstract] [Full Text] [PDF]

				S. Martin, A. K. Levine, Z. J. Chen, Y. Ughrin, and J. M. Levine Deposition of the NG2 Proteoglycan at Nodes of Ranvier in the Peripheral Nervous System J. Neurosci., October 15, 2001; 21(20): 8119 - 8128. [Abstract] [Full Text] [PDF]

				P. S. Fidler, K. Schuette, R. A. Asher, A. Dobbertin, S. R. Thornton, Y. Calle-Patino, E. Muir, J. M. Levine, H. M. Geller, J. H. Rogers, et al. Comparing Astrocytic Cell Lines that Are Inhibitory or Permissive for Axon Growth: the Major Axon-Inhibitory Proteoglycan Is NG2 J. Neurosci., October 15, 1999; 19(20): 8778 - 8788. [Abstract] [Full Text] [PDF]

				X. Fang, M. A. Burg, D. Barritt, K. Dahlin-Huppe, A. Nishiyama, and W. B. Stallcup Cytoskeletal Reorganization Induced by Engagement of the NG2 Proteoglycan Leads to Cell Spreading and Migration Mol. Biol. Cell, October 1, 1999; 10(10): 3373 - 3387. [Abstract] [Full Text]

				L. Goretzki, M. A. Burg, K. A. Grako, and W. B. Stallcup High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan J. Biol. Chem., June 11, 1999; 274(24): 16831 - 16837. [Abstract] [Full Text] [PDF]

				Corrections for vol. 114, p. 359 J. Cell Biol., May 31, 1999; 145(5): 1117 - 1117. [Full Text] [PDF]

				E. Tillet, F. Ruggiero, A. Nishiyama, and W. B. Stallcup The Membrane-spanning Proteoglycan NG2 Binds to Collagens V and VI through the Central Nonglobular Domain of Its Core Protein J. Biol. Chem., April 18, 1997; 272(16): 10769 - 10776. [Abstract] [Full Text] [PDF]

				L. Goretzki, C. R. Lombardo, and W. B. Stallcup Binding of the NG2 Proteoglycan to Kringle Domains Modulates the Functional Properties of Angiostatin and Plasmin(ogen) J. Biol. Chem., September 8, 2000; 275(37): 28625 - 28633. [Abstract] [Full Text] [PDF]